Clindamycin, endocarditis, hepatotoxicity.
D000293:Adolescent; D002512:Cephalothin / Q000008:administration & dosage / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury; D002981:Clindamycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004697:Endocarditis, Bacterial / Q000188:drug therapy*; D006801:Humans; D008034:Lincomycin / Q000009:adverse effects*; D008099:Liver / Q000187:drug effects*; D008297:Male; D013203:Staphylococcal Infections / Q000188:drug therapy*; D019966:Substance-Related Disorders / Q000150:complications*
D002981:Clindamycin; D008034:Lincomycin; D002512:Cephalothin